JM

Jyotirmoy Majumdar

Director Director DIN 06458246
DIN 06458246 First appointment Oct 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Oct 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyotirmoy Majumdar

Data last updated:

Jyotirmoy Majumdar has 14 years in corporate governance. Formerly with 1 company, such as Indian Medicines Pharmaceutical Corporation Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06458246
Primary Designation Director
First Appointment 01 Oct 2012
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director01 Oct 20121978₹164 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indian Medicines Pharmaceutical Corporation Limited
Premium access

Shareholding and investment profile for Jyotirmoy Majumdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotirmoy Majumdar

Jyotirmoy Majumdar has 14 years in corporate governance. Formerly with 1 company, such as Indian Medicines Pharmaceutical Corporation Limited. Engaged in General Business. Contributes to corporate operations.

Jyotirmoy Majumdar has expertise in General Business.

Jyotirmoy Majumdar has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available